TP53 and chronic obstructive pulmonary disease: Genetic variants (SNPs) are associated with COPD susceptibility [35,36,37,38,39], COPD severity (i.e., p53, [40]), COPD airway hyperreactivity [40], FEV1 [41], and therapeutic response [20,21,37,42,43].